REDCap alternatives for teams that need more than a survey tool

If you've outgrown REDCap, you're in the right place. WeGuide gives research teams whitelabel participant apps, regulatory grade eConsent, validated eCOA, and native wearable data, on a managed platform your IT team doesn't have to run. It connects to your existing REDCap instance if you're not ready to move off it.

No pressure, no hard sell. A 30 minute walkthrough with a research colleague who's built platforms like yours.

patient engagement

Used by leading research and medical institutes.

Why research teams look for a REDCap alternative

REDCap does one thing very well: it lets academic research teams capture structured data through forms and surveys without involving a software vendor. For observational data collection at a single academic site, it's hard to beat.

The pressure starts when studies get more ambitious. When a protocol needs validated eCOA instruments, push notification reminders, Apple Watch or Garmin data, regulatory grade eConsent, or a whitelabel mobile app that participants will actually open, REDCap's original scope doesn't stretch to fit. Teams end up duct taping REDCap to a mobile app vendor, an eConsent tool, and a wearable SDK, and then asking their IT department to hold the whole thing together on a self hosted server.

We built WeGuide for the teams that have lived through that. If you've outgrown REDCap but you don't want to jump straight to an enterprise platform like Medidata or Veeva, we're probably the right next step. If you haven't outgrown REDCap yet, that's completely fine. We'll tell you honestly if staying put is the better choice.

WeGuide vs REDCap Comparison
Functionality
Primary use case
Patient engagement platform with eCOA, eConsent, registries, telehealth
Academic survey and data collection
Primary use case
Patient engagement platform with eCOA, eConsent, wearables, registries
Clinical layer of the broader Vault life sciences cloud
Primary use case
Patient engagement platform with integrated eCOA, eConsent, wearables, registries, and wellbeing
DCT platform with eCOA, eConsent, EDC, telehealth, plus outcome measure and patient voice consulting
Primary use case
Patient engagement and clinical trial platform for mid-market sponsors, academic research, registries, DCTs
Decentralised trial delivery with virtual site services for pharma sponsors
Participant mobile app
Whitelabel iOS and Android under your brand
Mobile browser view, REDCap-branded
Business model
Pure technology
Platform plus consulting (Modus, inVibe)
Model
Technology platform only
Platform plus virtual site services
Hosting model
Managed cloud (ISO 27001, HIPAA, GDPR, 21 CFR Part 11, TGA Class I)
Self-hosted by each institution on its own servers
Target customer
Mid-market sponsors, academic CROs, digital health programmes, registries
Enterprise pharma running Vault across commercial, regulatory, quality, and clinical
Business model
Pure technology platform, no consulting scope
Platform plus consulting services (Modus Outcomes, inVibe)
Target customer
Mid-market sponsors, academic research, CROs, registries, digital health programmes
Pharma sponsors running DCTs with in home or community clinic visits
Commercial model
Managed SaaS, project-based pricing
Free, self-hosted (institutional IT required)
Whitelabel app
Yes
Thread-branded Study Companion and PatientFirst eCOA
Virtual site network
Not offered (partners with existing sites)
Proprietary Metasite mobile nurse network
Whitelabel mobile app
Yes, fully branded under your organisation
No, web view only
Configuration model
No-code programme builder, self-service by research teams
Dedicated Vault administrators, enterprise implementation projects
Target customer
Mid-market sponsors, academic research, CROs, registries, health organisations
Pharma sponsors, biotech, CROs running DCTs and hybrid trials
Delivery model
Technology platform you configure directly
Technology plus managed virtual site services (Metasite)
Wearable integration
Native Garmin, Apple Health, Google Fit
Not offered
Native EDC
Integrates with external EDCs
Native Thread EDC
Whitelabel app
Yes
Science 37-branded
eCOA and ePRO
Native with 200+ validated instrument library
Custom surveys, no validated instrument library
Typical deployment time
6 weeks (BRACE Trial: 6,000 participants across 5 countries)
Enterprise implementation cycles, typically multi-month
Device model
BYOD-first (participants' own phones)
BYOD-first with sensor and wearable integrations
Typical deployment time
6 weeks (BRACE Trial: 6,000 participants across 5 countries)
Project based, services led engagement cycles
eConsent with version control
Built in
Bolt-on, limited capability
Outcome measure consulting
Not offered
Modus Outcomes (acquired)
No-code programme builder
Yes
Services-led configuration
eConsent
Built-in with regulatory version control
Not available natively
Pricing model
Project-based, all modules included
Enterprise annual contracts, typically tied to broader Vault commitments
Whitelabel mobile app
Yes, fully branded under your organisation
Thread-branded Study Companion and PatientFirst eCOA
Pricing model
Project based, all modules included, scales to study complexity
Project based with services components bundled
200+ validated instrument library
Yes, integrated into Form Builder
Survey library exists, not validated instrument-first
Patient voice qualitative analytics
Not offered
inVibe (acquired)
Roadmap stability
Independent product roadmap
Post-eMed-acquisition shifts (2024)
Wearable integration
Native Garmin, Apple Health, Google Fit
Not available natively
Whitelabel mobile app
Yes, fully branded under your organisation
MyVeeva for Patients carries Veeva branding
eCOA instrument library
200+ validated instruments integrated into Form Builder
PatientFirst eCOA with global instrument library
eCOA and ePRO
Native with 200+ validated instrument library
eCOA and ePRO included in the DCT stack
Longitudinal engagement
Automated reminders, in-app messaging, push notifications, study companion
Email invitations, manual follow-up
eCOA and ePRO
Native with 200+ validated instrument library
MyVeeva for Patients covers eCOA and ePRO
eConsent
Built-in with regulatory version control and re-consent workflows
Integrated in platform
eConsent
Built-in with regulatory version control
Built-in with regulatory version control
Multi-language
Built-in translation management (proven on INHERIT study)
Manual translation per form
Telehealth
Built-in video visits and virtual site features
Virtual Visits as a core feature
Whitelabel mobile app
Yes, fully branded under your organisation
Science 37 branded participant experience
No-code programme builder
Yes, research teams configure studies directly
Form-level yes, but engagement and app experience require external tools
Wearable integration
Native Garmin, Apple Health, Google Fit
Supported through partner integrations
EDC
Integrates with external EDCs (Rave, Vault, REDCap, Viedoc, Clinion)
Native Thread EDC
Virtual site network (mobile nurses, community clinics)
Not offered; we coordinate with sponsor site networks
Metasite network (unique in market)
REDCap integration
Two-way sync via Integration Engine, pick up where REDCap leaves off
Native platform
Telehealth and virtual visits
Built-in video visit and virtual site features
MyVeeva for Patients covers virtual visits
Wearable integration
Native Garmin, Apple Health, Google Fit
Sensor and wearable integrations
Native wearable integration
Native Garmin, Apple Health, Google Fit
Supported through partner integrations
deployment-time
Typical 6 weeks for a full study launch
Depends on institutional IT; days for simple forms, months for custom builds
Patient registry
Built-in longitudinal registry (GenV: 100,000+ families)
Not a native use case
Patient registry
Built-in longitudinal registry capability (FSHD Global Registry)
Not a native offering
Telehealth
Built-in video visit and virtual site features
Built-in tele-visit capabilities
Regulatory certification
TGA certified Class I medical device software
Depends on each institution's hosting configuration
Employee wellbeing and population health
Built-in (Lendlease programme)
Outside the platform's scope
Employee wellbeing and population health
Built-in (Lendlease, GenV)
Not a primary use case
Patient registry
Built-in longitudinal registry (GenV: 100,000+ families)
Not a native use case
Pricing
Project-based, includes hosting, support, and all modules
Free licence, but institutional IT, server hosting, maintenance, and developer time not included
EDC
Form Builder covers eCRF use cases, deeper capture via Integration Engine
Vault EDC, a direct Medidata Rave competitor with strong Vault-customer adoption
Citizen science and multilingual community studies
Built-in (INHERIT)
Not a primary use case
Employee wellbeing and population health
Built-in (Lendlease programme)
Outside the platform's scope
Life sciences cloud breadth
Clinical and participant layer only
Full Vault platform: CRM, QMS, RIM, PromoMats, Clinical
Multi-language translation management
Built-in (INHERIT study proof)
Available in enterprise Vault
Outcome measure consulting
Not offered (technology only)
Modus Outcomes (acquired)
No-code programme builder
Yes, research teams configure studies directly
Services-led configuration
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11 and broad regulatory compliance across Vault
Patient voice qualitative analytics
Not offered
inVibe (acquired)
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11, DCT regulatory track record
Australian data residency
Yes
Regional options via Veeva global infrastructure
No-code programme builder
Yes, research teams configure studies directly
PatientFirst eCOA is no-code; broader configuration is services-led
Australian data residency
Yes
Not native
Regulatory certifications
TGA Class I, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11, HIPAA, GDPR
Ownership continuity
Independently roadmapped
Acquired by eMed in 2024
Australian data residency
Yes
Not a primary offering
Pricing model
Project-based, all modules included, technology only
Enterprise project-based, often includes consulting scope
Deployment time
Typical 6 weeks
Study-dependent, services-led timelines
Top alternatives to REDCap in 2026
Here's the shortlist of clinical trial software most teams evaluate when they're moving on from REDCap. Each one has a different sweet spot.
Alternative #1
WeGuide
A patient engagement and clinical trial platform built around the participant's mobile experience. WeGuide combines eCOA, eConsent, wearables, registries, telehealth, and analytics in a single platform with whitelabel apps under your own brand. TGA certified Class I, ISO 27001, 21 CFR Part 11, HIPAA and GDPR compliant. Strong fit for academic research institutions, CROs, and mid-market sponsors who need engagement and multi-modal data, not just surveys. Deploy timelines average six weeks.
Best For
patient engagement studies, longitudinal registries, eCOA and ePRO trials, wearable data collection, multilingual multisite studies.
Alternative #2
Oracle Life Sciences
Oracle Life Sciences empowers sponsors, contract research organizations (CROs), and research sites with a unified, interoperable platform designed to streamline the entire clinical development lifecycle. By integrating clinical trial management, data collection (EDC), randomization (RTSM), and pharmacovigilance into a single cloud-based ecosystem, Oracle eliminates data silos and secures high-fidelity information.
Best For
Global pharmaceutical companies, mid-market biotech, and CROs requiring enterprise-grade scalability, multi-site Phase II-IV trials.
Alternative #3
Medidata Rave
The gold standard for large, global, late stage pharma trials. Enterprise pricing, 3 to 6 month implementation cycles, deepest CRF library in the industry. Overkill for most teams leaving REDCap, but unmatched if you're running multi site Phase II to IV trials.
Best For
top 50 pharma sponsors and large CROs with enterprise budgets.
Alternative #4
OpenClinica
Open source EDC with a paid enterprise SaaS edition. Ranks #1 in Google for "edc clinical trials" and has 20 years of regulatory history. Thin eCOA module (Participate), no native wearables.
Best For
CROs and device companies needing deep EDC and edit check functionality at mid-market pricing.
Alternative #5
Clinion
A more affordable EDC from India with CDISC-ready data standards, eCOA, and eConsent bolted on. Cost-competitive for teams priced out of Medidata or Veeva.
Best For
cost-sensitive CROs running Phase I to III trials who want an enterprise feature set without enterprise pricing.

All-in-one platform

WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.

eConsent

Regulatory grade electronic consent with version tracking, re-consent workflows, digital signatures, and audit trails. REDCap doesn't have native eConsent, so teams either pair it with a second vendor or manage consent on paper.
We Guide

Screening

Screen participants against eligibility criteria directly in the app before they enrol, with branching logic and automated routing to the right study arm.

Data collection

Native eCOA and ePRO with a 200+ validated instrument library, custom forms with branching logic, and multimodal capture through forms, video, active tasks, and sensors.

Telehealth

Built in video visits, asynchronous messaging, and remote assessments that keep participants engaged with their research team between site visits.

Continuous engagement, not once-off surveys

Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →

Push notifications and reminders

Scheduled push notifications, smart reminders, and re engagement flows that meet participants where they are on their phone rather than waiting for them to check an email.
We Guide

Study companion

A dedicated study companion that explains what's coming next, why it matters, and how to complete it ensuring participants stay informed and on track throughout the entire journey.

Educational content and gamification

Contextual educational content, progress tracking, and gentle gamification that keep participants engaged across multi year longitudinal studies.

Mobile multimodal collection

Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.

Forms

Native eCOA and ePRO instruments with branching logic, validation, and offline support. 200+ validated instruments ready to drop into a study.
We Guide

Video

Structured video capture for symptom diaries, gait analysis, and remote clinical assessments, stored securely against the participant record.

Pathology

Seamlessly set up integrations with your pathology providers to collect DNA or blood data from participants, streamlining the clinical data pipeline directly within the study workflow.

Sensors

Native Garmin, Apple Health, Google Fit, and FindAir integrations that sync passive wearable and sensor data straight into the study database.

Whitelabel: your study, your brand

WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.

Your brand end-to-end

Native iOS and Android apps under your organisation's name, logo, and colours not a WeGuide-branded web view.
We Guide

App store distribution

Published under your developer account on the Apple App Store and Google Play so participants download an app that clearly belongs to your institution.

Multilingual out of the box.

Translation management for multisite, multi-country studies, proven on INHERIT across multilingual communities.

Where WeGuide goes further

For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.

Whitelabel participant mobile apps

Native wearable and sensor data

Built-in eConsent with version control

Continuous engagement, not once-off surveys

Managed cloud, not self-hosted

Multilingual studies out of the box

Integration with REDCap

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Certified

Certified Class I medical device software under the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.
12x

Faster

Your own platform ready in weeks and changes are made in minutes

94%

Adherence Rates

High patient engagement and better quality data

10x

Cost Saving

Reduce financial and technology risk when creating a secure health app

200K+

Patients Impacted

With our ease of use and roll out, our apps have engaged 200k+ users

Where REDCap excels

We're not going to pretend REDCap isn't a brilliant tool. It's used in tens of thousands of studies worldwide for a reason, and anyone comparing it to a commercial platform deserves an honest picture of what REDCap does well.

It's free at the licence level. For an academic team running a straightforward observational study or a one-off survey, zero licence cost is a genuine advantage. No procurement, no vendor approvals, no budget conversations.

It has a 7,000+ institution community. When your research office has already used REDCap for a decade, there's enormous institutional knowledge around it. IRB teams know the templates, biostatisticians know the data exports, research coordinators know the workflow. That familiarity has real value.

It's flexible at the form level. Drag-and-drop survey building, branching logic, calculated fields, and validation rules are all solid. For many academic studies, REDCap's form builder is all a team needs.

It has IRB-approved templates. Many institutions have pre-approved REDCap templates for common study types, which shortens ethics review time. That's a real workflow advantage that commercial platforms have to earn.

If your study fits comfortably inside those strengths, honestly, staying on REDCap is the right call. We'd rather tell you that than sell you something you don't need.

WeGuide works alongside REDCaps

You don't have to choose. Many of the research teams we work with keep REDCap for structured eCRF data capture and connect it to WeGuide for participant-facing experience, eCOA, eConsent, and wearable data. The Integration Engine supports two-way sync through the REDCap API, so teams can run hybrid architectures without rebuilding what already works.

How the switch works

For teams that are ready to move beyond REDCap or run WeGuide alongside it, here's how a typical onboarding plays out.

Discovery Call

A 30-minute conversation with one of our research delivery team. We look at your protocol, your current REDCap setup, and what's actually blocking you. No pressure, no sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide. If you're keeping REDCap for eCRF data, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.

We Guide

Participant Onboarding

The whitelabel app goes live. Your research coordinators invite participants, who download the app under your organisation's brand. Support, push notification templates, and consent flows are all ready.

Ongoing Support

You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.

Case studies: research teams that moved beyond surveys
BRACE Trial (Murdoch Children's Research Institute)

Murdoch Children's Research Institute. A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. The study launched across five countries with 6,000+ participants in six weeks during the pandemic. Adherence exceeded 90%. MCRI needed engagement architecture that REDCap couldn't deliver on that timeline.

GenV (Generation Victoria)

A population health study tracking more than 100,000 Victorian families from birth. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years. WeGuide is the platform GenV trusted to do that.

Lendlease wellbeing programme

A patient registry for facioscapulohumeral muscular dystrophy, running longitudinally with participant-reported outcomes, wearable integration, and a patient community experience. The kind of registry REDCap could start but couldn't sustain at scale.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study across more than 100,000 Victorian families. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""
Susan Clifford
Susan Clifford
Senior Research Officer
GEN V logo
“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”
Kaya Gardiner
Kaya Gardiner
Trial Project Manager
Murdoch children Research Institute
"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."
Emma Photo
Emma Weatherley
Managing Director
FSHD Global
"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."
KATE Cranwell
Kate Cranwell
Manager
Western Health
"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."
Testimonial Photo
Paul Eleftheriou
Chief Medical Officer
Western Health

Questions

Straight answers on how WeGuide compares to Science 37, what migration looks like, and when staying on Science 37 is the right call.

Contact us

Isn't REDCap free? Why would I pay for WeGuide?

REDCap's licence is free, but the full cost of running a REDCap study rarely is. Institutions carry the cost of server hosting, IT maintenance, security patching, disaster recovery, and developer time to build anything beyond basic forms. For studies that need mobile apps, wearables, eConsent, or engagement features, teams typically add a second or third vendor on top of REDCap. When you add it up, the total cost of ownership for a moderately complex study often matches or exceeds a WeGuide licence, which comes with managed hosting, support, and every module included.

Can I migrate data from REDCap to WeGuide?

Yes. We support data import from REDCap exports, and our Integration Engine can pull live data through the REDCap API during the migration period. Most teams don't do a hard cutover. They run the two platforms side by side until they're confident, then gradually consolidate.

Does WeGuide have an IRB-approved template library like REDCap?

Not in the same institutional sense that REDCap does, because each WeGuide study is configured for its sponsor. What we do offer is a library of validated eCOA and ePRO instruments ready to drop into a study, and we work alongside IRB teams during study setup to pre-populate approved templates. In practice, around 60% of new studies on our platform reuse a previously approved base. If your IRB has a strong preference for REDCap-based templates, that's another good reason to run both platforms in parallel through the Integration Engine.

Is WeGuide a full replacement for REDCap?

For some teams, yes. For others, no, and we'll tell you honestly which camp you're in. If your study is straightforward academic data collection through forms, with no need for mobile engagement, wearables, or eConsent, REDCap is still an excellent free option and we're genuinely happy to recommend it. WeGuide becomes the right choice when you need eCOA or ePRO instruments, a participant-facing mobile app, native wearable data, regulatory-compliant eConsent, or longitudinal engagement at scale. Many of our customers run both in parallel through our Integration Engine.

Can WeGuide integrate with our existing REDCap instance?

Yes. Our Integration Engine connects to REDCap through its API with two-way sync. If your institution has invested years in REDCap and isn't going to walk away from that data, you don't need to. You can keep REDCap for structured eCRF capture and layer WeGuide on top for participant experience, eCOA, eConsent, and wearables.

Does WeGuide support longitudinal studies the way REDCap does?

Yes, and this is actually where WeGuide tends to outperform REDCap significantly. Longitudinal studies live or die on participant retention, and our engagement architecture is built exactly for that. Automated scheduling, push notification reminders, in-app content, and the study companion experience are the reasons GenV trusted us to run a multi-year population health study across 100,000+ families.

Compare WeGuide to other clinical trial platforms

Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
OpenClinica
Open-source EDC
Medable
DCT for top-50 pharma
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack

Never miss an update

Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

Thank you! Your submission has been received!
Oops! Something went wrong. Please try again.

Certified and Compliant by Leading Standards